Adenosine TriphosphateApoptosisCells, Cultured
Dr. Alan Rosmarin, MD
NPI1225040025
- Medicare services, 2016
- 271
- Part D claims, 2016
- 51
- Publications
- 10
- Clinical trials
- 2
- State license
- 1
- Practice address
- 115 Lincoln St, Framingham, MA 01702
- Practice phone
- Call (508) 856-3550
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Rosmarin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alan Rosmarin is a hematologist and oncologist in Framingham, Massachusetts
Dr. Rosmarin practices in Framingham, Massachusetts.
Dr. Rosmarin's NPI, 1225040025, was assigned on August 12, 2006. Dr. Rosmarin holds Massachusetts license 52497.
NPI and contact details
- NPI
- 1225040025NPI Registry (opens in a new tab)
- NPI enumeration date
- August 12, 2006
- NPI status
- Active
- Practice phone
- (508) 856-3550
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Alan Rosmarin's practice address is in Framingham, Massachusetts
Dr. Rosmarin's practice address in the NPI Registry is 115 Lincoln St, Framingham, MA 01702, in Middlesex County. The practice phone is (508) 856-3550.
- NPI Registry address115 Lincoln St, Framingham, MA 01702 · Middlesex CountyPhone(508) 856-3550
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Alan Rosmarin's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosmarin practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Rosmarin's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Rosmarin practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alan Rosmarin is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Rosmarin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rosmarin is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Rosmarin
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
429hematologists and oncologists in Massachusetts
4hematologists and oncologists in Framingham
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alan Rosmarin billed Medicare for 271 services in 2016
CMS data shows 271 Medicare services from Dr. Rosmarin across 6 procedure codes in 2016. Medicare paid $16,167 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2016271
Paid by Medicare$16,167
Procedure codes6
Dr. Rosmarin compared with the Massachusetts median for hematologists and oncologists, 2016
- Dr. Rosmarin
- Massachusetts median
- Medicare services
- 271vs 49545% below
- Part D claims
- 51vs 15166% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Rosmarin's most billed Medicare procedure codes, 2016
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosmarin?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosmarin and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alan Rosmarin's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Rosmarin's median patient age at 70, with 0% women.
Dr. Rosmarin's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Alan Rosmarin wrote 51 Medicare Part D claims in 2016
In 2016, Dr. Rosmarin wrote 51 Medicare Part D claims. They cover 3 drugs, with $295,802 in total drug cost.
Part D claims, 201651
Drugs named by CMS3
Total drug cost$295,802
Dr. Rosmarin's most prescribed drugs by claims, 2016
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Rosmarin by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alan Rosmarin has 10 publications on record
Dmand AI links 10 papers to Dr. Rosmarin, published from 2011 to 2019. 2011 was the busiest year, with 2. The most frequent topics are GA-Binding Protein Transcription Factor, Mice, Knockout and Transcription Factors. Dr. Rosmarin's most frequent co-authors are Jan Cerny, MD, Bruce Allen Barton, MD and James N. Butera, MD.
Papers10
Years published2011 to 2019
Dr. Rosmarin's papers by year, 2011 to 2019
Topics Dr. Rosmarin writes about most
- GA-Binding Protein Transcription Factor
- Mice, Knockout
- Transcription Factors
Dr. Rosmarin's most frequent co-authors
Recent publications by Dr. Rosmarin
Proc Natl Acad Sci U S A
Antineoplastic AgentsBenzamidesCell Cycle
See who Dr. Rosmarin researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rosmarin works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alan Rosmarin has worked on 2 clinical trials
Dmand AI links Dr. Rosmarin to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Lymphoma, Follicular and Lymphoma, Mantle-Cell.
Conditions in Dr. Rosmarin's trials
- Lymphoma, Non-Hodgkin
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
Investigators on the most trials with Dr. Rosmarin
- Andrew M. Evens, DO, MS2 shared trials
- Abraham Sebastian Kanate, MD2 shared trials
- Anjali S. Advani, MD1 shared trial
Recent clinical trials with Dr. Rosmarin
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Lymphoma, Mantle-CellLymphoma, Non-HodgkinBendamustineBortezomibLenalidomide
Lymphoma, FollicularLymphoma, Non-HodgkinBendamustinBortezomibLenalidomide
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Sources for Dr. Alan Rosmarin's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alan Rosmarin
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alan Rosmarin's NPI number?
Dr. Alan Rosmarin's NPI number is 1225040025. It was assigned on August 12, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Alan Rosmarin?
Dr. Alan Rosmarin is a hematologist and oncologist in Framingham, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Alan Rosmarin practice?
Dr. Rosmarin practices at 115 Lincoln St, Framingham, MA 01702.
What is Dr. Alan Rosmarin's office phone number?
The practice phone on file for Dr. Rosmarin is (508) 856-3550.
What is Dr. Alan Rosmarin's medical license number?
Dr. Rosmarin holds Massachusetts license 52497.
Does Dr. Alan Rosmarin accept Medicare?
Yes. CMS data shows Dr. Rosmarin billed Medicare for 271 services in 2016.
What services does Dr. Alan Rosmarin bill to Medicare?
In 2016, Dr. Rosmarin's most billed Medicare services were hospital inpatient care (99232), office visit, established patient (99214) and office visit, established patient (99213).
What drugs does Dr. Alan Rosmarin prescribe most?
In 2016 Medicare Part D data, Dr. Rosmarin's most prescribed drugs by claims were Allopurinol, Sprycel and Prednisone.
How long has Dr. Alan Rosmarin been practicing?
Dr. Rosmarin's NPI was assigned in 2006.
Does Dr. Alan Rosmarin do research?
Dmand AI links 10 publications to Dr. Rosmarin, published from 2011 to 2019. Dr. Rosmarin has worked on 2 clinical trials.
Who does Dr. Alan Rosmarin publish with?
Dr. Rosmarin's most frequent co-authors are Jan Cerny, MD (2 shared papers), Bruce Allen Barton, MD (1 shared paper) and James N. Butera, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card